Allarity Therapeutics, Inc. (ALLR) vs Lipocine Inc. (LPCN)
A side-by-side comparison of Allarity Therapeutics, Inc. and Lipocine Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$1.00HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT
LPCN
Lipocine Inc.
$2.08HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — ALLR vs LPCN
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)LPCN -88.8% (-35.5%/yr)LPCN compounded faster over this window
Log scale — wide-divergence pair
ALLR LPCN
ALLR vs LPCN: by the numbers
- •LPCN is the larger company ($17M vs $16M market cap).
- •Both run net losses; LPCN's is the smaller (-755.13% vs -3575.07% net margin).
Metrics side by side
Valuation
| Metric | ALLR | LPCN |
|---|---|---|
| P/S ratio | 46.11 | 10.93 |
| P/B ratio | 4.50 | 0.79 |
Profitability
| Metric | ALLR | LPCN |
|---|---|---|
| Gross margin | 107.54% | -334.26% |
| Operating margin | -3939.06% | -524.69% |
| Net margin | -3575.07% | -755.13% |
| ROE | -348.81% | -54.45% |
| ROIC | -41.81% | -57.74% |
Growth (annualized)
| Metric | ALLR | LPCN |
|---|---|---|
| Total return CAGR (5Y) | N/A | -34.76% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.